I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Douglas M. Lankler net worth and biography

Douglas Lankler Biography and Net Worth

EVP of Pfizer

Doug Lankler joined Pfizer in 1999 and currently serves as general counsel. Prior to being named general counsel, Doug was Pfizer's chief compliance and risk officer, a role he assumed in 2006.

Prior to joining the company, Doug was with the United States Department of Justice as an Assistant U.S. Attorney in the Southern District of New York. Doug was a recipient of the United States Attorney General's Distinguished Service Award.

Doug graduated from the State University of New York at Albany and Cornell Law School. He and his wife, Jill, have three children and reside in Larchmont, N.Y.

What is Douglas M. Lankler's net worth?: The estimated net worth of Douglas M. Lankler is at least $3.49 million as of April 29th, 2020. Mr. Lankler owns 135,375 shares of Pfizer stock worth more than $3,491,321 as of December 3rd. This net worth approximation does not reflect any other investments that Mr. Lankler may own. Additionally, Mr. Lankler receives a salary of $1,760,000.00 as EVP at Pfizer. Learn More about Douglas M. Lankler's net worth.
How old is Douglas M. Lankler?: Mr. Lankler is currently 58 years old. There are 7 older executives and no younger executives at Pfizer. The oldest executive at Pfizer is Dr. Mikael Dolsten M.D., Ph.D., Chief Scientific Officer and President of Research & Development, who is 66 years old. Learn More on Douglas M. Lankler's age.
What is Douglas M. Lankler's salary?: As the EVP of Pfizer Inc., Mr. Lankler earns $1,760,000.00 per year. There are 3 executives that earn more than Mr. Lankler. The highest earning executive at Pfizer is Dr. Albert Bourla D.V.M., Ph.D., Chairman of the Board & CEO, who commands a salary of $4,050,000.00 per year. Learn More on Douglas M. Lankler's salary.
How do I contact Douglas M. Lankler?: The corporate mailing address for Mr. Lankler and other Pfizer executives is 235 EAST 42ND STREET, NEW YORK NY, 10017. Pfizer can also be reached via phone at (212) 733-2323. Learn More on Douglas M. Lankler's contact information.
Has Douglas M. Lankler been buying or selling shares of Pfizer?: Douglas M. Lankler has not been actively trading shares of Pfizer during the past quarter. Most recently, Douglas M. Lankler sold 40,000 shares of the business's stock in a transaction on Friday, November 26th. The shares were sold at an average price of $54.37, for a transaction totalling $2,174,800.00. Learn More on Douglas M. Lankler's trading history.
Who are Pfizer's active insiders?: Pfizer's insider roster includes Ronald Blaylock (Director), Albert Bourla (DVM), Loretta Cangialosi (VP), William Carapezzi, Jr. (EVP), Albert D.V.M. (DVM), Frank Damelio (EVP), Frank D'Amelio (CFO & Exec. VP ), Jennifer Damico (SVP), Jennifer Damico (SVP), Scott Gottlieb (Director), Rady Johnson (Insider), Douglas Lankler (EVP), Alexander Mackenzie (EVP), Laurie Olson (Insider), Ian Read (CEO), Dawn Rogers (EVP), Sally Susman (Insider), and John Young (Insider). Learn More on Pfizer's active insiders.
Are insiders buying or selling shares of Pfizer?: In the last year, Pfizer insiders bought shares 2 times. They purchased a total of 4,000 shares worth more than $107,650.00. The most recent insider tranaction occured on October, 30th when Director Scott Gottlieb bought 1,000 shares worth more than $28,240.00. Insiders at Pfizer own 0.1% of the company. Learn More about insider trades at Pfizer.
Information on this page was last updated on 10/30/2024.

Douglas M. Lankler Insider Trading History at Pfizer

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/26/2021	Sell	40,000	$54.37	$2,174,800.00
4/29/2020	Sell	65,000	$37.85	$2,460,250.00	135,375
2/1/2019	Sell	5,000	$42.75	$213,750.00	83,592
1/30/2019	Sell	38,800	$41.19	$1,598,172.00	83,592
3/13/2018	Sell	50,000	$36.89	$1,844,500.00	133,057
5/4/2016	Sell	29,700	$33.69	$1,000,593.00	124,920

Douglas M. Lankler Buying and Selling Activity at Pfizer

Pfizer Company Overview

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Today's Range

Now: $25.79

$25.72

$25.90

50 Day Range

MA: $27.83

$24.80

$30.20

2 Week Range

Now: $25.79

$24.48

$31.54

Volume

11,964,262 shs

Average Volume

38,338,863 shs

Market Capitalization

$146.15 billion

P/E Ratio

34.85

Dividend Yield

6.41%

Beta

0.65

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

Douglas Lankler Biography and Net Worth

What is Douglas M. Lankler's net worth?

How old is Douglas M. Lankler?

What is Douglas M. Lankler's salary?

How do I contact Douglas M. Lankler?

Has Douglas M. Lankler been buying or selling shares of Pfizer?

Who are Pfizer's active insiders?

Are insiders buying or selling shares of Pfizer?